GP
Geoffrey M. Parker
Chief Financial Officer

Geoffrey M. Parker insider trades: Allogene Therapeutics (ALLO) stock buys and sales

Chief Financial Officer, Allogene Therapeutics Last trade Oct 21, 2026 128 Form 4 filings
$91K
Sold, last 12 months
2 sales
$106K
Bought, last 12 months
1 buy
54
Open-market trades
since 2011
9
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Geoffrey reports to the SEC

and 3 more companies

Open-market buys and sales

54 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 21, 2026ALLO↓ Sell$49K
Feb 2, 2026ALLO↓ Sell$42K
Nov 12, 2025PRGO↑ Buy$106K
Oct 21, 2025ALLO↓ Sell$46K
Aug 18, 2025PRGO↑ Buy$100K
May 12, 2025PRGO↑ Buy$95K
Feb 3, 2025ALLO↓ Sell$8K
Jan 30, 2024ALLO↑ Buy$683
Jul 27, 2023BTTX↑ Buy$500K
Jun 13, 2023PRGO↑ Buy$331K
Apr 10, 2023BTTX↑ Buy$250K
Mar 6, 2023PRGO↑ Buy$190K
Jun 13, 2022BTTX↑ Buy$36K
Mar 29, 2022BTTX↑ Buy$32K
Dec 16, 2021PRGO↑ Buy$184K
Dec 14, 2021BTTX↑ Buy$99K
Mar 17, 2021PRGO↑ Buy$103K
Mar 5, 2021CCXI↓ Sell$1.8M
Dec 10, 2020TCDA↑ Buy$102K
May 12, 2020TCDA↑ Buy$1.1M
Mar 23, 2020CCXI↓ Sell$1.1M
Mar 10, 2020TCDA↑ Buy$147K
Nov 19, 2019TCDA↑ Buy$686K
Aug 13, 2019TCDA↑ Buy$970K
May 30, 2019CCXI↓ Sell$154K
Nov 13, 2018TCDA↑ Buy$149K
Nov 12, 2018PRGO↑ Buy$196K
Jul 2, 2018TCDA↑ Buy$1.1M
Dec 9, 2016SNSS↑ Buy$14K
Nov 21, 2016PRGO↑ Buy$222K
May 26, 2016SNSS↑ Buy$4K
May 25, 2016SNSS↑ Buy$25K
May 13, 2016CCXI↑ Buy$161K
Jan 11, 2016CCXI↑ Buy$93K
Dec 11, 2015CCXI↑ Buy$145K
May 27, 2015CCXI↓ Sell$102K
Mar 23, 2015ANAC↑ Buy$157K
Sep 8, 2014ANAC↑ Buy$144K
Mar 24, 2014ANAC↑ Buy$101K
Mar 18, 2014ANAC↑ Buy$54K
Dec 6, 2013CCXI↑ Buy$77K
Dec 6, 2013CCXI↑ Buy$26K
Nov 26, 2013ANAC↑ Buy$134K
Nov 25, 2013ANAC↑ Buy$128K
Aug 13, 2013ANAC↑ Buy$417K
Jun 19, 2013ANAC↑ Buy$120K
Jun 18, 2013ANAC↑ Buy$52K
Jun 18, 2013ANAC↑ Buy$52K
Aug 22, 2012ANAC↑ Buy$31K
Jun 5, 2012ANAC↑ Buy$38K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ALLO insiders

Open-market trades in the last 12 months

About Geoffrey M. Parker's insider trades

Geoffrey M. Parker is Chief Financial Officer at Allogene Therapeutics (ALLO). Since May 10, 2011, Geoffrey has reported 46 open-market purchases worth $9.0M and 8 sales worth $3.3M on SEC Form 4. In the last 12 months: 1 buy ($106K) and 2 sales ($91K).

Their filings also include grants and awards (58 filings), option exercises (25 filings), shares withheld for taxes (14 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.